Oprymea
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oprymea, covering 2024-08-20 to 2024-08-20. Get the full timeline:
Most recent: EMA Authorised: Oprymea (pramipexole dihydrochloride monohydrate) — Krka, d.d., Novo mesto